Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
Overview
Authors
Affiliations
Background: There is a gap between evidence and practice in the management of cardiovascular (CV) risk. Previous research indicated benefits from community-based, multi-faceted interventions to screen, diagnose, and manage CV risk in people with hypertension.
Methods: The Heart Outcomes Prevention and Evaluation 4 Canada pilot study (HOPE 4) was a quasi-experimental pre-post interventional study, involving one community each in Hamilton, Ontario and Surrey, British Columbia, Canada. Individuals aged ≥50 years with newly diagnosed or poorly controlled hypertension were included. The intervention was comprised of: (i) simplified diagnostic/treatment algorithms implemented by community health workers (firefighters in British Columbia and community health workers in Ontario) guided by decision support and counselling software; (ii) recommendations for evidence-based CV medications and lifestyle modifications; and (iii) support from family/friends to promote healthy behaviours. The intervention was developed as part of the international Heart Outcomes Prevention and Evaluation 4 Canada pilot study trial and adapted to the Canadian context. The primary outcome was the change in Framingham Risk Score 10-year CV disease risk estimate between baseline and 6 months.
Results: Between 2016 and 2017, a total of 193 participants were screened, with 37 enrolled in Surrey, and 19 in Hamilton. Mean age was 69 years (standard deviation 11), with 54% female, 27% diabetic, and 73% with a history of hypertension. An 82% follow-up level had been obtained at 6 months. Compared to baseline, there were significant improvements in the Framingham Risk Score 10-year risk estimate (30.6% vs 24.7%, < 0.01), and systolic blood pressure (153.1 vs 136.7 mm Hg, < 0.01). No significant changes in lipids or healthy behaviours were noted.
Conclusions: A comprehensive approach to health care delivery, using a community-based intervention with community health workers, supported by mobile-health technologies, has the potential to significantly reduce cardiovascular risk, but further evaluation is warranted.
Schwalm J, Joseph P, Leong D, Lopez-Lopez J, Onuma O, Bhatt P Lancet Reg Health Am. 2025; 42:100964.
PMID: 40034111 PMC: 11873640. DOI: 10.1016/j.lana.2024.100964.
Task-sharing with community health workers to treat hypertension: a scoping review.
Inagaki Y, Matsushita K, Appel L, Perry H, Neupane D J Hypertens. 2024; 42(12):2041-2054.
PMID: 39469922 PMC: 11556888. DOI: 10.1097/HJH.0000000000003834.
Patil S, Bhayani V, Yoshida Y, Bushweller L, Udoh E, Todorov I Front Med (Lausanne). 2024; 11:1305190.
PMID: 38831986 PMC: 11144929. DOI: 10.3389/fmed.2024.1305190.
Adherence to Cardiovascular Prevention Guidelines in an Academic Centre.
Soltani I, Beaulieu M, Sestier M, Shen H, Hillani A, Matteau A CJC Open. 2023; 5(7):530-536.
PMID: 37496787 PMC: 10366625. DOI: 10.1016/j.cjco.2023.03.010.
Refining a primary care shared decision-making aid for lifestyle change: a mixed-methods study.
Heron N, OConnor S, Kee F, Thompson D, Cupples M, Donnelly M BJGP Open. 2021; 6(1).
PMID: 34853008 PMC: 8958746. DOI: 10.3399/BJGPO.2021.0100.